🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Philadelphia-Negative ALL

CAV Regimen for R/R Ph- B-ALL NCT05657652NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: cladribine, cytarabine,venetoclax Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia NCT07394153Phase 213 sites📍 Barcelona📍 Barcelona📍 Barcelona Grupo Español de Enfermedades Mieloproliferativas Crónicas … · Tests: Pacritinib A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) NCT06661915Phase 231 sites📍 Irvine📍 Orange📍 Palo Alto National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine and Cedazuridine, Iadademstat Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma NCT06918431Phase 28 sites📍 Phoenix📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomogra… Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients NCT07039877Phase 21 site📍 Monterrey Hospital Universitario Dr. Jose E. Gonzalez · Tests: Venetoclax low dose with itraconazole RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL NCT05127148n/a2 sites📍 Paraná📍 CABA Grupo Argentino de Tratamiento de la Leucemia Aguda · Tests: Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category. RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL. NCT06250959Phase 21 site📍 Suzhou Chen Suning · Tests: Blinatumomab Injection [Blincyto], Doxorubicin MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms NCT07863466n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia NCT07564453Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Blinatumomab, Induction Chemotherapy, Hyper-CVAD, Allogeneic hematopoietic stem cell transplantation, CAR-T cell therapy Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL NCT06481241NA1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: CAR-T cells, Venetoclax Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia NCT03739814Phase 2285 sites📍 Birmingham📍 Anchorage📍 Anchorage National Cancer Institute (NCI) · Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Inotuzumab Ozogamicin Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia NCT01371630Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Inotuzumab Ozogamicin ALL Backbone in AYAs NCT07227584Phase 21 site📍 Boston Dana-Farber Cancer Institute · Tests: Blinatumomab, Oncaspar, Cyclophosphamide, Cytarabine, Dexamethasone A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL) NCT06287528Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: 19-28z/IL-18 CAR T cells Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL NCT06886074Phase 21 site📍 Monterrey Hospital Universitario Dr. Jose E. Gonzalez · Tests: Short course of blinatumomab Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL) NCT06785324NA1 site📍 Chicago University of Chicago · Tests: Nutrition Intervention, Exercise intervention Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia NCT05660473Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Vincristine, Daunorubicin, Cyclophosphamide, Pegaspargase, Prednisone Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL NCT06387121Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Vincristine, Cyclophosphamide, Dexamethasone, Venetoclax, Inotuzumab ozogamicin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy